GRC-388XX

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameGRC-388XX
Drug Alias NameGRC388XX
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlenmark Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A